Cambridge, MA, Nov 10th ,2025 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collaboration with Eli Lilly (“Lilly”) that the two parties will combine Insilico’s state-of-the-art Pharma.AI platforms with Lilly’s development and disease expertise to jointly discover and advance innovative therapies.

Cannabis may be a pain-management substitute for people experiencing chronic or acute pain from conditions like cancer, according to new research from the University of Georgia.

TORONTO (November 10, 2025)—Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such as intestinal worms, scabies and river blindness, according to results from a clinical trial presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this in using insurance claims data. They found that semaglutide and tirzepatide – marketed as Ozempic and Mounjaro – reduced the risk of serious cardiovascular events by up to 18 percent.